The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

BACKGROUND: This study aims at identifying predictors of the treatment decision of German physicians with regard to a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted protease inhibitor (PI/r) -based initial treatment regimen. METHODS: The study is based on a sub analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlich, Jörg, Groß, Mona, Kuhlmann, Alexander, Bogner, Johannes, Heiken, Hans, Stoll, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203724/
https://www.ncbi.nlm.nih.gov/pubmed/28050254
http://dx.doi.org/10.1186/s40545-016-0092-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203724/
https://www.ncbi.nlm.nih.gov/pubmed/28050254
http://dx.doi.org/10.1186/s40545-016-0092-4

Ejemplares similares